PharmaCielo Ltd. (PCLO.V) Research

PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.

Market snapshot

Symbol
PCLO.V
Price
$0.08
Day change
-6.25%
Market cap
$14.1M
P/E ratio
-3.10x
52-week range
0.035-0.165
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 1 day

Peer companies

  • Aleafia Health Inc. (AH.TO)
  • Australis Capital Inc. (AUSA.CN)
  • CanaFarma Hemp Products Corp. (CNFA.CN)
  • Khiron Life Sciences Corp. (KHRN.V)
  • Mojave Brands Inc. (MOJO.CN)
  • Sunniva Inc. (SNN.CN)
  • Sproutly Canada Inc. (SPR.CN)
  • StateHouse Holdings Inc. (STHZ.CN)

Open PharmaCielo Ltd. (PCLO.V) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.